Study findings may lead to new treatments to fight deadly C. difficile infections

Study findings may lead to new treatments to fight deadly C. difficile infections

A University of California, Irvine-led study suggests that the glucosyltransferase domain (GTD) is a...
read more
NIH funds large Phase 3 clinical trial to test repurposed drugs for treating COVID-19 symptoms

NIH funds large Phase 3 clinical trial to test repurposed drugs for treating COVID-19 symptoms

Using an ACTIV master protocol, the trial will foc...
read more
An electronic nose to detect harmful atmospheric free radicals

An electronic nose to detect harmful atmospheric free radicals

An international project involving researchers at ...
read more
Unbalanced progesterone may cause preterm or prolonged labor in some pregnant women

Unbalanced progesterone may cause preterm or prolonged labor in some pregnant women

New research by the National Institutes of Health ...
read more
Mosquito protein study could lead to therapeutics against deadly viruses

Mosquito protein study could lead to therapeutics against deadly viruses

The mosquito protein AEG12 strongly inhibits the f...
read more
Novel dual-targeting drug could become a next-generation treatment for EBV-related cancers

Novel dual-targeting drug could become a next-generation treatment for EBV-related cancers

A Hong Kong Baptist University-led (HKBU) research...
read more
Researchers discover specific blood biomarker that predicts kidney transplant rejection

Researchers discover specific blood biomarker that predicts kidney transplant rejection

Researchers at the University of Pittsburgh School...
read more
Study: First influenza infection does not make people immune to future flu viruses

Study: First influenza infection does not make people immune to future flu viruses

A child's first influenza infection shapes the...
read more
FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma

FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma

Today, the U.S. Food and Drug Administration appro...
read more
APO-Oxazepam

APO-Oxazepam

NOTICE: This Consumer Medicine Information (CMI) i...
read more
1 2 3